FBP3 was analyzable in 102 bladder cancer cases: 25 tumors revealed a low expression (25%) (Figure 3E), 57 tumors showed a moderate expression (57%) (Figure 3F&3G), and 20 a strong expression of FBP3 (20%)(Figure 3H). This evidence concerns the gene FUBP3 and urinary bladder carcinoma.